Bruin Biometrics, LLC

Bruin Biometrics, LLC, with the slogan "Prevention made real," was founded in 2009 through a technology license from the University of California, Los Angeles, displaying a steadfast commitment to leveraging technology for enhancing healthcare delivery. The company's innovation is driven by a collaborative effort between its R&D and clinical teams, both comprised of experts in their respective fields. Bruin Biometrics applies rigorous scientific, technical, and clinical standards to develop products that address unmet and urgent clinical needs.

The company's pipeline consists of solutions for wound care, orthopedic care, and real-time data capture, analytics, and reporting. Utilizing passive sensor technology, Bruin Biometrics' portable devices generate actionable data for evidence-based assessment, aiming to modernize care pathways through the development and integration of biometric-sensor-based medical devices.

One of the key products, Provizio® SEM Scanner, is the first hand-held wireless scanner with intelligence inside, designed for quick and convenient PI/PU risk assessments. It serves as an adjunct to routine clinical skin assessment on the sacrum and heels, providing enhanced pressure injury/ulcer insights and risk identification on admission and five days earlier than visual skin assessment, regardless of skin tone (Oknonkwo H., et al 2020; Bates Jensen B., et al 2009).

The company, headquartered in the United States, had its last investment of $1.40M grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the National Institutes of Health on 07 December 2018.